# Savara Inc: filings

SVRA · Nasdaq · CIK 1160308 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/svra.md) · [Financials](/companies/svra/financials.md) · [Filings](/companies/svra/filings.md) · [Insiders](/companies/svra/insiders.md)

## Reports and events: 402 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 301, 8-K 286, 10-Q 53, 3 44, SC 13G/A 38, SC 13G 30, 424B5 29, 424B3 21, CORRESP 20, DEF 14A 19, 10-K 18, EFFECT 17, S-8 17, 425 16, DEFA14A 16, UPLOAD 13, SCHEDULE 13G/A 12, S-3 9, 144 8, POS AM 8, SC 13D/A 7, 8-K/A 6, PRE 14A 6, S-1/A 6, CT ORDER 5, SCHEDULE 13G 5, ARS 4, FWP 3, 424B4 2, D 2, S-1 2, S-3/A 2, SC 13D 2, SCHEDULE 13D/A 2, 10-K/A 1, 25 1, 8-A12B 1, CERTNAS 1, S-1MEF 1, S-3MEF 1, S-4 1, S-4/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:05 ET | [10-Q](/filings/0001193125-26-344585.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344585 |
| 2026-06-08 | 16:15 ET | [8-K](/filings/0001193125-26-261770.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-261770 |
| 2026-05-12 | 16:05 ET | [10-Q](/filings/0001193125-26-219371.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219371 |
| 2026-04-24 | 16:22 ET | [DEF 14A](/filings/0001193125-26-177353.md) | Proxy statement, period 2026-06-04 | 0001193125-26-177353 |
| 2026-03-13 | 08:30 ET | [8-K](/filings/0001193125-26-105099.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-105099 |
| 2026-03-13 | 08:10 ET | [10-K](/filings/0001193125-26-105076.md) | Annual report, period 2025-12-31 | 0001193125-26-105076 |
| 2026-01-27 | 08:10 ET | [8-K](/filings/0001193125-26-023378.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-023378 |
| 2026-01-09 | 08:00 ET | [8-K](/filings/0001193125-26-008301.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-008301 |
| 2025-11-14 | 16:27 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000852.md) | Ownership report, active investor, amended | 0001072613-25-000852 |
| 2025-11-12 | 16:05 ET | [10-Q](/filings/0001193125-25-277525.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277525 |
| 2025-10-30 | 16:26 ET | [8-K](/filings/0001193125-25-258629.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-258629 |
| 2025-10-29 | 16:03 ET | [8-K](/filings/0001193125-25-256290.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-256290 |
| 2025-09-02 | 09:13 ET | [8-K](/filings/0001193125-25-193507.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-193507 |
| 2025-08-13 | 08:05 ET | [10-Q](/filings/0000950170-25-107631.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107631 |
| 2025-06-06 | 16:48 ET | [8-K](/filings/0001193125-25-137150.md) | 5.07 Shareholder vote results | 0001193125-25-137150 |
| 2025-05-27 | 08:13 ET | [8-K](/filings/0001193125-25-126273.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-126273 |
| 2025-05-13 | 16:03 ET | [10-Q](/filings/0000950170-25-070283.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070283 |
| 2025-04-25 | 16:18 ET | [DEF 14A](/filings/0001193125-25-096895.md) | Proxy statement, period 2025-06-05 | 0001193125-25-096895 |
| 2025-04-25 | 16:03 ET | [10-K/A](/filings/0000950170-25-058690.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-058690 |
| 2025-03-31 | 06:09 ET | [8-K](/filings/0001193125-25-067658.md) | 1.02 Termination of a material agreement | 0001193125-25-067658 |
| 2025-03-27 | 17:40 ET | [SCHEDULE 13D/A](/filings/0000950170-25-046213.md) | Ownership report, active investor, amended | 0000950170-25-046213 |
| 2025-03-27 | 07:30 ET | [10-K](/filings/0000950170-25-045731.md) | Annual report, period 2024-12-31 | 0000950170-25-045731 |
| 2025-03-26 | 17:01 ET | [8-K](/filings/0001193125-25-064145.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-064145 |
| 2025-01-23 | 16:05 ET | [8-K](/filings/0001193125-25-011453.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-011453 |
| 2025-01-13 | 08:35 ET | [8-K](/filings/0001193125-25-005034.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005034 |
| 2024-11-12 | 16:00 ET | [10-Q](/filings/0000950170-24-125292.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125292 |
| 2024-08-14 | 20:45 ET | [SC 13D/A](/filings/0001072613-24-000639.md) | Ownership report, active investor, amended | 0001072613-24-000639 |
| 2024-08-12 | 16:05 ET | [10-Q](/filings/0000950170-24-095403.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095403 |
| 2024-06-28 | 10:10 ET | [8-K](/filings/0001193125-24-171564.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-171564 |
| 2024-06-26 | 06:40 ET | [8-K](/filings/0001193125-24-168501.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-168501 |
| 2024-06-10 | 17:07 ET | [8-K/A](/filings/0001193125-24-158429.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-158429 |
| 2024-06-07 | 16:15 ET | [8-K](/filings/0001193125-24-157366.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-157366 |
| 2024-05-09 | 16:10 ET | [10-Q](/filings/0000950170-24-056954.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056954 |
| 2024-04-26 | 16:14 ET | [DEF 14A](/filings/0001193125-24-118077.md) | Proxy statement, period 2024-06-06 | 0001193125-24-118077 |
| 2024-04-12 | 17:26 ET | [SC 13D/A](/filings/0001193125-24-094908.md) | Ownership report, active investor, amended | 0001193125-24-094908 |
| 2024-04-12 | 16:07 ET | [8-K](/filings/0001193125-24-094640.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-24-094640 |
| 2024-03-07 | 16:05 ET | [10-K](/filings/0000950170-24-027920.md) | Annual report, period 2023-12-31 | 0000950170-24-027920 |
| 2024-02-16 | 08:31 ET | [8-K](/filings/0001193125-24-038108.md) | 1.01 Entry into a material agreement | 0001193125-24-038108 |
| 2024-01-25 | 16:06 ET | [8-K](/filings/0001193125-24-015391.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-015391 |
| 2024-01-05 | 08:00 ET | [8-K](/filings/0001193125-24-002889.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-002889 |
| 2023-11-09 | 16:10 ET | [10-Q](/filings/0000950170-23-062040.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062040 |
| 2023-08-10 | 16:11 ET | [10-Q](/filings/0000950170-23-041323.md) | Quarterly report, period 2023-06-30 | 0000950170-23-041323 |
| 2023-07-26 | 16:57 ET | [SC 13D/A](/filings/0001072613-23-000396.md) | Ownership report, active investor, amended | 0001072613-23-000396 |
| 2023-07-19 | 16:30 ET | [SC 13D/A](/filings/0001193125-23-189644.md) | Ownership report, active investor, amended | 0001193125-23-189644 |
| 2023-07-13 | 17:18 ET | [8-K](/filings/0001193125-23-186640.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-186640 |
| 2023-06-09 | 08:02 ET | [8-K](/filings/0001193125-23-164012.md) | 5.07 Shareholder vote results | 0001193125-23-164012 |
| 2023-06-08 | 16:20 ET | [8-K](/filings/0001193125-23-163526.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-163526 |
| 2023-05-15 | 08:15 ET | [10-Q](/filings/0000950170-23-021981.md) | Quarterly report, period 2023-03-31 | 0000950170-23-021981 |
| 2023-04-28 | 16:12 ET | [DEF 14A](/filings/0001193125-23-126955.md) | Proxy statement, period 2023-06-08 | 0001193125-23-126955 |
| 2023-03-30 | 17:14 ET | [8-K](/filings/0001193125-23-085762.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-085762 |

Page 1 of 9. [Older](/companies/svra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.